Improving function in age-related macular degeneration: A randomized clinical trial

Ophthalmology

Volumn 120, Issue 8, 2013, Pages 1649-1655

  Rovner, Barry W ^a   Casten, Robin J ^a   Hegel, Mark T ^b   Massof, Robert W ^c   Leiby, Benjamin E ^a   Ho, Allen C ^d   Tasman, William S ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COPING BEHAVIOR; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; PROBLEM SOLVING; PROBLEM SOLVING THERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; SUPPORTIVE THERAPY; TARGETED VISION FUNCTION; THERAPY EFFECT; VISUAL ACUITY; VISUAL SYSTEM FUNCTION;

AGED; AGED, 80 AND OVER; COGNITIVE THERAPY; FEMALE; HEALTH STATUS; HUMANS; MACULAR DEGENERATION; MALE; PROBLEM SOLVING; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY;

EID: 84881162020     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.01.022     Document Type: Article

References (28)

1. S.L. Fine, J.W. Berger, M.G. Maguire, and A.C. Ho Age-related macular degeneration N Engl J Med 342 2000 483 492
2. D.S. Friedman, B.J. O'Colmain, B. Munoz Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572
3. D.B. Rein, J.S. Wittenborn, X. Zhang Vision Health Cost-Effectiveness Study Group Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments Arch Ophthalmol 127 2009 533 540
4. J.S. Slakter, and M. Stur Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment Surv Ophthalmol 50 2005 263 273
5. R.A. Williams, B.L. Brody, and R.G. Thomas The psychosocial impact of macular degeneration Arch Ophthalmol 116 1998 514 520
6. S.M. Szabo, P.A. Janssen, and K. Khan Older women with age-related macular degeneration have a greater risk of falls: a physiological profile assessment study J Am Geriatr Soc 56 2008 800 807
7. A. Wysong, P.P. Lee, and F.A. Sloan Longitudinal incidence of adverse outcomes of age-related macular degeneration Arch Ophthalmol 127 2009 320 327
8. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
9. T.S. Chang, N.M. Bressler, J.T. Fine MARINA Study Group Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial Arch Ophthalmol 125 2007 1460 1469
10. D.S. Boyer, A.N. Antoszyk, C.C. Awh MARINA Study Group Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2007 246 252
11. G.R. Watson Low vision in the geriatric population: rehabilitation and management J Am Geriatr Soc 49 2001 317 330
12. J.A. Stelmack, X.C. Tang, D.J. Reda LOVIT Study Group Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT) Arch Ophthalmol 126 2008 608 617
13. M.M. Leinhaas, and R.W. Massof Clinical management of patients with low vision in the U.S. health care system R.W. Massof, L. Lidoff, Issues in Low-Vision Rehabilitation: Service Delivery, Policy, and Funding 2001 AFB Press New York 39 52
14. P. Cuijpers, A. van Straten, and L. Warmerdam Problem solving therapies for depression: a meta-analysis Eur Psychiatry 22 2007 9 15
15. P.N. Noavalis, S.J. Rojcewicz Jr., and R. Peele Clinical Manual of Supportive Psychotherapy 1993 American Psychiatric Press Washington, DC 57-86
16. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
17. M. Von Korff, E.H. Wagner, and K. Saunders A chronic disease score from automated pharmacy data J Clin Epidemiol 45 1992 197 203
18. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J Gen Intern Med 16 2001 606 613
19. R.W. Massof A systems model for low vision rehabilitation. I. Basic concepts Optom Vis Sci 72 1995 725 736
20. R.W. Massof, L. Ahmadian, and L.L. Grover The Activity Inventory: an adaptive visual function questionnaire Optom Vis Sci 84 2007 763 774
21. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058
22. J. Heckhausen, C. Wrosch, and R. Schulz A motivational theory of life-span development Psychol Rev 117 2010 32 60
23. H.W. Wahl, O. Schilling, and S. Becker Age-related macular degeneration and change in psychological control: role of time since diagnosis and functional ability J Gerontol B Psychol Sci Soc Sci 62 2007 P90 P97
24. R.W. Massof An interval-scaled scoring algorithm for visual function questionnaires Optom Vis Sci 84 2007 689 704
25. B.L. Brody, A.C. Roch-Levecq, and A.C. Gamst Self-management of age-related macular degeneration and quality of life: a randomized controlled trial Arch Ophthalmol 120 2002 1477 1483
26. B.W. Rovner, R.J. Casten, and M.T. Hegel Preventing depression in age-related macular degeneration Arch Gen Psychiatry 64 2007 886 892
27. Low Vision Depression Prevention Trial for Age Related Macular Degeneration (VITAL). ClinicalTrials.gov Identifier NCT00769015. Available at: http://clinicaltrials.gov/ct2/show/NCT00769015. Accessed June 6, 2012.
28. R. Casten, B.W. Rovner, B.E. Leiby, and W. Tasman Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration [letter] Arch Ophthalmol 128 2010 506 508